Beanfields Secures New Accounts; Boosh Hires Marsham Food Brokers For Continued Canadian Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or...
Year: 2022
MDIC Publishes Framework on External Evidence Methods for Medical Devices
The Framework aims to assist stakeholders with use of new, innovative, and existing statistical methods for evidence fusion from data...
The Garage’s Population Health Management Platform, Bridge, earns ONC Health IT Certification from Drummond Group
ORLANDO, Fla.--(BUSINESS WIRE)--The Garage today announced that its platform Bridge has achieved Office of the National Coordinator for Health Information...
GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care
CHICAGO & DUBLIN--(BUSINESS WIRE)--Providing excellent care inside and outside of the traditional hospital is the new normal for patients, clinicians,...
Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test
VANCOUVER, BC / ACCESSWIRE / April 28, 2022 / Gemina Laboratories Ltd. (CSE:GLAB) (FRA:8I7) (the "Company" or "Gemina") is pleased...
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's...
Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Third Quarter of Fiscal Year 2022 Results
EAGAN, MN / ACCESSWIRE / April 28, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
- Executing on broad vaccine development program, with new clinical studies in COVID-19 and influenza together with GSK to validate...
Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age
Submission to Regulators Globally Is Based on Phase 2/3 Studies of mRNA-1273 in Young ChildrenCAMBRIDGE, MA / ACCESSWIRE / April...
Truepill Appoints John Foster as Chief People Officer
SAN MATEO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Truepill, the digital health platform connecting telehealth, diagnostics, and pharmacy infrastructure...
CORRECTION: Orion Group Interim Report 1–3/2022
ORION CORPORATION INTERIM REPORT 1–3/2022 28 APRIL 2022 at 16:00 EEST CORRECTION: Orion Group Interim Report 1–3/2022 This is a correction to the...
Philips and Prisma Health sign multi-year, long-term strategic partnership to innovate healthcare across the enterprise and unlock the power of patient data
Doctor showing images on Philips Enterprise Viewer April 28, 2022 South Carolina’s largest health system adopts Philips software solutions for...
Delcath Systems to Host First Quarter 2022 Results
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
Wellframe Addresses the Caregiver Crises Through an Expanded Program Aimed to Assist 250,000 Members by 2025
New program to help lift caregivers’ burden by identifying, personalizing and continuously supporting their evolving needsBOSTON, April 28, 2022 (GLOBE...
After Doubling Members and Revenue in 2021, Beam Will Hire 100 More Employees By End of 2022
Fast-growing employee benefits company to surpass 400 employees by end of yearCOLUMBUS, Ohio, April 28, 2022 (GLOBE NEWSWIRE) -- Beam,...
Scilex Holding Company a Majority-Owned Subsidiary of Sorrento Therapeutics, Inc., Appoints Highly Accomplished Life Science Executive, Elizabeth Czerepak, as Executive Vice President, Chief Financial Officer (CFO) and Chief Business Officer (CBO)
SAN DIEGO and PALO ALTO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or...
XBiotech Announces French National Agency (ANSM) Approval and National Cancer Institute (INSA) funding to Support Phase I/II/III Clinical Study for Natrunix™ in Combination with Trifluridine/Tipiracil (TASKIN) for Treatment of Metastatic Colorectal Cancer
ANSM approves NATRUNIX for INSA funded Phase-I-III Study at 20 Leading Medical Centers in FranceAUSTIN, Texas, April 28, 2022 (GLOBE...
Mountain Valley MD Holdings Provides Business Update
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)...
BioPorto A/S – Annual General Meeting
April 28, 2022Announcement no. 9 BioPorto A/S - Annual General Meeting Today, BioPorto A/S held its Annual General Meeting. The...
Pure Extracts Receives Initial Purchase Order from Nova Scotia Liquor Corporation Cannabis (NSLC Cannabis)
VANCOUVER, British Columbia, April 28, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...